KB

Krishna Bakshi

Director Director DIN 00921926
DIN 00921926 First appointment Feb 1991 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 1991
Shareholding value Locked Premium profile

About Krishna Bakshi

Krishna Bakshi has 35 years in corporate governance. Formerly with 1 company, such as Cradel Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 00921926
Primary Designation Director
First Appointment 21 Feb 1991
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Cradel Pharmaceuticals Pvt Ltd U24233WB1991PTC050938
Director 21 Feb 1991 1991 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cradel Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Krishna Bakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Bakshi

Krishna Bakshi has 35 years in corporate governance. Formerly with 1 company, such as Cradel Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Krishna Bakshi is associated with 0 companies as a director.

Krishna Bakshi has expertise in General Business.

Krishna Bakshi has 35 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available